These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
10. The treatment of multiple sclerosis with beta-interferon. Poser CM Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413 [No Abstract] [Full Text] [Related]
11. Natalizumab (Tysabri) returns. Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289 [No Abstract] [Full Text] [Related]
12. Interferon beta in multiple sclerosis. Current policy is sensible. Price C BMJ; 1997 Feb; 314(7080):600-1. PubMed ID: 9055728 [No Abstract] [Full Text] [Related]
13. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis? Oger J; Gibbs E Nat Clin Pract Neurol; 2006 Feb; 2(2):76-7. PubMed ID: 16932528 [No Abstract] [Full Text] [Related]
14. Interferon beta in multiple sclerosis. Some form of compromise must be accepted. Peltola J; Keranen T BMJ; 1997 Feb; 314(7080):602. PubMed ID: 9055733 [No Abstract] [Full Text] [Related]
15. [Clinical control of multiple sclerosis patients treated with interferon beta in a hospital in Peru]. Portillo-Vallenas R; Rojas-Huerto E; Inca-Parra J Rev Neurol; 2005 Nov 1-15; 41(9):575-6. PubMed ID: 16254867 [No Abstract] [Full Text] [Related]
17. Interferon-beta for multiple sclerosis: Long-term benefits? Rudick RA; Cutter G Ann Neurol; 2007 Apr; 61(4):283-5. PubMed ID: 17444503 [No Abstract] [Full Text] [Related]
18. Treatment of children and adolescents with multiple sclerosis. Banwell B Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672 [TBL] [Abstract][Full Text] [Related]